Business Description
Encompass Health Corp
NAICS : 621498
SIC : 8093
Description
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. It operates in two segments: inpatient rehabilitation and home health and hospice. The Inpatient rehabilitation segment contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas. The Home health and hospital segment provides skilled home health services through agencies concentrated in the southeastern United States and Texas, which include nursing, physical, occupational, and speech therapy, social work, and hospice services.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.05 | |||||
| Equity-to-Asset | 0.28 | |||||
| Debt-to-Equity | 1.76 | |||||
| Debt-to-EBITDA | 3.57 | |||||
| Interest Coverage | 4.03 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 1.78 | |||||
| Beneish M-Score | -2.74 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 6 | |||||
| 3-Year EBITDA Growth Rate | 8.5 | |||||
| 3-Year EPS without NRI Growth Rate | 12.1 | |||||
| 3-Year FCF Growth Rate | -30.4 | |||||
| 3-Year Book Growth Rate | 14.2 | |||||
| Future 3-5Y Total Revenue Growth Rate Industry Rank | 5.55 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 47.35 | |||||
| 9-Day RSI | 42.78 | |||||
| 14-Day RSI | 42.42 | |||||
| 6-1 Month Momentum % | -15.04 | |||||
| 12-1 Month Momentum % | -17.61 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.24 | |||||
| Quick Ratio | 1.24 | |||||
| Cash Ratio | 0.22 | |||||
| Days Sales Outstanding | 45.56 | |||||
| Days Payable | 242.22 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.06 | |||||
| Dividend Payout Ratio | 0.26 | |||||
| 3-Year Dividend Growth Rate | 2.5 | |||||
| Forward Dividend Yield % | 1.24 | |||||
| 5-Year Yield-on-Cost % | 2.47 | |||||
| 3-Year Average Share Buyback Ratio | -0.2 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 95.89 | |||||
| Operating Margin % | 13.78 | |||||
| Net Margin % | 6.22 | |||||
| ROE % | 17.15 | |||||
| ROA % | 4.79 | |||||
| ROIC % | 9.27 | |||||
| ROC (Joel Greenblatt) % | 24.56 | |||||
| ROCE % | 11.96 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 14.83 | |||||
| Forward PE Ratio | 14.48 | |||||
| PE Ratio without NRI | 14.83 | |||||
| Shiller PE Ratio | 14.89 | |||||
| Price-to-Owner-Earnings | 18.7 | |||||
| PEG Ratio | 3.16 | |||||
| PS Ratio | 0.92 | |||||
| PB Ratio | 2.44 | |||||
| Price-to-Free-Cash-Flow | 24.14 | |||||
| Price-to-Operating-Cash-Flow | 6.35 | |||||
| EV-to-EBIT | 11.3 | |||||
| EV-to-Forward-EBIT | 11.23 | |||||
| EV-to-EBITDA | 8.25 | |||||
| EV-to-Forward-EBITDA | 7.92 | |||||
| EV-to-Revenue | 1.56 | |||||
| EV-to-Forward-Revenue | 1.73 | |||||
| EV-to-FCF | 39.87 | |||||
| Price-to-Projected-FCF | 0.94 | |||||
| Price-to-DCF (Earnings Based) | 0.91 | |||||
| Price-to-DCF (FCF Based) | 1.95 | |||||
| Price-to-Median-PS-Value | 0.81 | |||||
| Earnings Yield (Greenblatt) % | 8.86 | |||||
| Forward Rate of Return (Yacktman) % | 11.71 |
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:EHC
Executives
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 5,267.6 | ||
| EPS (TTM) ($) | 3.27 | ||
| Beta | 0.85 | ||
| Volatility % | 34.84 | ||
| 14-Day RSI | 42.42 | ||
| 14-Day ATR ($) | 1.485763 | ||
| 20-Day SMA ($) | 49.2075 | ||
| 12-1 Month Momentum % | -17.61 | ||
| 52-Week Range ($) | 42.163832 - 59.639997 | ||
| Shares Outstanding (Mil) | 99.78 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Encompass Health Corp Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
Encompass Health Corp Analysis
Share your researchHeadlines
See More
No news.